The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the country on Thursday, the World Health Organisation said.

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

More than 1,400 people have been diagnosed and 438 have died